Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Biofrontera Inc. (BFRIW)

    Price:

    0.07 USD

    ( - -0.03 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    BFRIW
    Name
    Biofrontera Inc.
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    Price
    0.070
    Market Cap
    815.952k
    Enterprise value
    5.030M
    Currency
    USD
    Ceo
    Hermann Luebbert
    Full Time Employees
    92
    Ipo Date
    2021-10-29
    City
    Woburn
    Address
    120 Presidential Way

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Viatris Inc.

    VALUE SCORE:

    5

    Symbol
    VTRS
    Market Cap
    13.418B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare

    2nd position

    Neurocrine Biosciences, Inc.

    VALUE SCORE:

    9

    Symbol
    NBIX
    Market Cap
    15.190B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare

    The best

    Amphastar Pharmaceuticals, Inc.

    VALUE SCORE:

    10

    Symbol
    AMPH
    Market Cap
    1.160B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.459
    P/S
    0.242
    P/B
    -1.632
    Debt/Equity
    -1.072
    EV/FCF
    -0.776
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0.185
    Earnings yield
    -2.178
    Debt/assets
    0.248
    FUNDAMENTALS
    Net debt/ebidta
    0.145
    Interest coverage
    -54.508
    Research And Developement To Revenue
    0.090
    Intangile to total assets
    0.001
    Capex to operating cash flow
    -0.005
    Capex to revenue
    0.001
    Capex to depreciation
    0.070
    Return on tangible assets
    -0.825
    Debt to market cap
    0.527
    Piotroski Score
    3.000
    FUNDAMENTALS
    PEG
    0.010
    P/CF
    -0.812
    P/FCF
    -1.016
    RoA %
    -82.375
    RoIC %
    -1.217k
    Gross Profit Margin %
    61.660
    Quick Ratio
    0.751
    Current Ratio
    0.956
    Net Profit Margin %
    -42.347
    Net-Net
    -1.345
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.999
    Revenue per share
    4.190
    Net income per share
    -1.774
    Operating cash flow per share
    -1.004
    Free cash flow per share
    -0.999
    Cash per share
    0.775
    Book value per share
    -0.499
    Tangible book value per share
    -0.502
    Shareholders equity per share
    -0.499
    Interest debt per share
    0.567
    TECHNICAL
    52 weeks high
    0.097
    52 weeks low
    0.070
    Current trading session High
    0.097
    Current trading session Low
    0.070
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.816
    logo

    Country
    IL
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.428
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -5.209
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.176
    logo

    Country
    IL
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.236
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.002
    logo

    Country
    CA
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.050
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.722
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.841
    DESCRIPTION

    Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

    NEWS